124 related articles for article (PubMed ID: 9215249)
1. Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: effects of cetirizine.
Atkins PC; Zweiman B; Moskovitz A; von Allmen C; Ciliberti M
J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):806-11. PubMed ID: 9215249
[TBL] [Abstract][Full Text] [Related]
2. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine.
Zweiman B; Atkins PC; Moskovitz A; von Allmen C; Ciliberti M; Grossman S
J Allergy Clin Immunol; 1997 Sep; 100(3):341-7. PubMed ID: 9314346
[TBL] [Abstract][Full Text] [Related]
3. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study.
Nielsen PN; Skov PS; Poulsen LK; Schmelz M; Petersen LJ
Clin Exp Allergy; 2001 Sep; 31(9):1378-84. PubMed ID: 11591187
[TBL] [Abstract][Full Text] [Related]
4. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin.
Zweiman B; Kaplan AP; Tong L; Moskovitz AR
J Allergy Clin Immunol; 1997 Jul; 100(1):104-9. PubMed ID: 9257794
[TBL] [Abstract][Full Text] [Related]
5. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
Allergy; 2000 Apr; 55(4):382-5. PubMed ID: 10782524
[TBL] [Abstract][Full Text] [Related]
6. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
Allergy; 2000 Sep; 55(9):888-91. PubMed ID: 11003455
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.
Michel L; De Vos C; Rihoux JP; Burtin C; Benveniste J; Dubertret L
J Allergy Clin Immunol; 1988 Jul; 82(1):101-9. PubMed ID: 2899102
[TBL] [Abstract][Full Text] [Related]
8. Temporal patterns of mediator release during developing cutaneous late-phase reactions.
Zweiman B; Von Allmen C
Clin Exp Allergy; 2000 Jun; 30(6):856-62. PubMed ID: 10848904
[TBL] [Abstract][Full Text] [Related]
9. Comparison of inflammatory events in skin sites with and without cutaneous late-phase reactions after prominent immediate IgE-mediated responses.
Zweiman B; Moskovitz AR; von Allmen C
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):110-5. PubMed ID: 9449509
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil infiltration: effects of H1 antihistamines.
Fadel R; David B; Rassemont R; Herpin-Richard N; Borgnon A; Rihoux JP
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1094-6. PubMed ID: 1677013
[TBL] [Abstract][Full Text] [Related]
11. The effect of cetirizine and loratadine on codeine-induced histamine release in human skin in vivo assessed by cutaneous microdialysis.
Perzanowska M; Malhotra D; Skinner SP; Rihoux JP; Bewley AP; Petersen LJ; Church MK
Inflamm Res; 1996 Sep; 45(9):486-90. PubMed ID: 8891761
[TBL] [Abstract][Full Text] [Related]
12. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction.
Charlesworth EN; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Allergy Clin Immunol; 1989 May; 83(5):905-12. PubMed ID: 2469708
[TBL] [Abstract][Full Text] [Related]
13. Patterns of inflammatory responses following rechallenge of skin late-phase allergic reaction sites.
Zweiman B; von Allmen C; Schwartz LB; Atkins PC
J Allergy Clin Immunol; 1998 Jul; 102(1):94-8. PubMed ID: 9679852
[TBL] [Abstract][Full Text] [Related]
14. The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions.
Petersen LJ; Skov PS
Inflamm Res; 1999 Oct; 48(10):527-32. PubMed ID: 10563469
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo.
Fadel R; Herpin-Richard N; Rihoux JP; Henocq E
Clin Allergy; 1987 Jul; 17(4):373-9. PubMed ID: 2887304
[TBL] [Abstract][Full Text] [Related]
16. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Clough GF; Bennett AR; Church MK
Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inflammatory events during developing immunoglobulin E-mediated late-phase reactions and delayed-hypersensitivity reactions.
Zweiman B; Moskovitz AR; von Allmen C
Clin Diagn Lab Immunol; 1998 Jul; 5(4):574-7. PubMed ID: 9665969
[TBL] [Abstract][Full Text] [Related]
18. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
Petersen LJ; Skov PS
Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
[TBL] [Abstract][Full Text] [Related]
19. Use of cetirizine to investigate non-H1 effects of second-generation antihistamines.
Townley RG; Okada C
Ann Allergy; 1992 Feb; 68(2):190-6. PubMed ID: 1346737
[TBL] [Abstract][Full Text] [Related]
20. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions.
Zweiman B; Atkins PC; von Allmen C; Gleich GJ
J Allergy Clin Immunol; 1991 May; 87(5):984-92. PubMed ID: 1709185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
